RReeffeerreenncceess
1 Hart RG. Warfarin in atrial fibrillation: underused in the elderly, often
inappropriately used in the young. Heart1999; 8822 : 539–40.
FFuurrtthheerr rreeaaddiinngg
Stroke Prevention in Atrial Fibrillation Investigators. Adjusted dose
warfarin versus low-intensity, fixed dose warfarin plus aspirin for
high-risk patients with atrial fibrillation: stroke prevention in atrial
fibrillation III. Lancet1996; 334488 : 633–8.
Stroke Prevention In Atrial Fibrillation Investigators. Stroke Prevention
in Atrial Fibrillation Study. Final results. Circulation1991; 8844 : 527–39.
Hardman SM, Cowie M. Fortnightly review(:) anticoagulation in heart
disease. BMJ: 1999; 331188 : 238–44 (website version at http://www.bmj.com)..)
Petersen P, Botsen G, Godfredsen J et al.Placebo-controlled, randomised
trial for prevention of thromboembolic complications in chronic atrial
fibrillation. The Copenhagen AFASAK Study. Lancet1989;ii: 175–9.